Shorvon et al. [20] conducted a multicenter, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and tolerability of levetiracetam as add-on therapy in patients with ...

University of Virginia Brain Institute and School of Medicine researchers have received an initial $9.3 million award from the National Institutes of Health for a $30 million clinical trial to ...

In April 2022, this was an off-label use of levetiracetam. See NICE's information on prescribing medicines. If convulsive status epilepticus does not respond to a second-line treatment, consider ...

In the end, the researchers determined the drugs – levetiracetam, fosphenytoin and valproate – were about equally effective, but that they stopped status epilepticus in only about 47% of adult trial ...

Focal motor status epilepticus associated with right hemispheric ... phenytoin was given for 5 years together with varying combinations of levetiracetam, clobazam, oxcarbazepine, lamotrigine ...

We studied the effects of treating status epilepticus (SE) induced by lithium and pilocarpine at postnatal day 15 (P15) or 28 (P28), on the severity of acute SE and of SE-induced epileptogenesis.

Purpose: The role of levetiracetam in different epileptic, nonepileptic, neurologic, and psychiatric disorders is discussed. Summary: Levetiracetam, an antiepileptic drug (AED), was first approved ...